As of April 9, 2026, the CDC reports 1,714 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—now at 92.5% for kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold and leaving roughly 286,000 children susceptible. This surge, driven by importations from global hotspots and rapid transmission (R0 of 12–18) in under-vaccinated communities, threatens the U.S.'s measles elimination status achieved in 2000. Ongoing outbreaks in states like South Carolina, Utah, and Texas fuel trader consensus for elevated totals, though public health interventions could curb spread; watch weekly CDC surveillance updates every Thursday for case trends and vaccination response data.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,595,970 Vol.
$7,595,970 Vol.
31 dic 2026
↑2k
99%
↑3k
82%
↑4k
59%
↑5k
39%
↑7,5k
14%
↑10k
13%
↑12,5k
9%
$7,595,970 Vol.
$7,595,970 Vol.
31 dic 2026
↑2k
$38,177 Vol.
99%
↑3k
$44,781 Vol.
82%
↑4k
$148,320 Vol.
59%
↑5k
$203,277 Vol.
39%
↑7,5k
$159,348 Vol.
14%
↑10k
$6,483,790 Vol.
13%
↑12,5k
$343,513 Vol.
9%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—now at 92.5% for kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold and leaving roughly 286,000 children susceptible. This surge, driven by importations from global hotspots and rapid transmission (R0 of 12–18) in under-vaccinated communities, threatens the U.S.'s measles elimination status achieved in 2000. Ongoing outbreaks in states like South Carolina, Utah, and Texas fuel trader consensus for elevated totals, though public health interventions could curb spread; watch weekly CDC surveillance updates every Thursday for case trends and vaccination response data.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Dec 1, 2025, 12:56 PM ET
Volume
$7,595,970Data di fine
31 dic 2026Mercato aperto
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—now at 92.5% for kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold and leaving roughly 286,000 children susceptible. This surge, driven by importations from global hotspots and rapid transmission (R0 of 12–18) in under-vaccinated communities, threatens the U.S.'s measles elimination status achieved in 2000. Ongoing outbreaks in states like South Carolina, Utah, and Texas fuel trader consensus for elevated totals, though public health interventions could curb spread; watch weekly CDC surveillance updates every Thursday for case trends and vaccination response data.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,595,970Data di fine
31 dic 2026Mercato aperto
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 confirmed measles cases across 33 U.S. jurisdictions, with 94% linked to 17 new outbreaks this year amid declining MMR vaccination coverage—now at 92.5% for kindergartners in the 2024–2025 school year, below the 95% herd immunity threshold and leaving roughly 286,000 children susceptible. This surge, driven by importations from global hotspots and rapid transmission (R0 of 12–18) in under-vaccinated communities, threatens the U.S.'s measles elimination status achieved in 2000. Ongoing outbreaks in states like South Carolina, Utah, and Texas fuel trader consensus for elevated totals, though public health interventions could curb spread; watch weekly CDC surveillance updates every Thursday for case trends and vaccination response data.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti